Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.09 +0.13 (6.63%)
Previous Close $1.96    52 Week High $4.76 
Open $2.00    52 Week Low $1.46 
Day High $2.14    P/E N/A 
Day Low $1.93    EPS $-1.91 
Volume 4,122,848